In summary, our findings reveal that cPKM enhances ICC growth, metastasis, and resistance to paclitaxel by promoting STMN1 and TGFB1 expression and by causing abnormal activation of HSCs, exacerbating fibrosis, and ultimately leading to vascular collapse. This evidence concerns the gene CKM and intrahepatic cholangiocarcinoma.